Consolidative stereotactic radiotherapy for oligo-residual non-small cell lung cancer after first-line chemoimmunotherapy: A single-arm, phase 2 trial from China

Journal:

PLOS Medicine

Published:

2025-08-02

DOI:

10.1371/journal.pmed.1004680

Affiliations:

8

Authors:

13

Go to article

Institutions	Authors	Share
Fudan University Shanghai Cancer Center (FUSCC), China	7.100000	0.55
Shanghai Medical College (SHMC), Fudan University, China	2.700000	0.21
Tianjin Medical University Cancer Institute and Hospital, TMU, China	2.000000	0.15
Zhongshan Hospital, Fudan University, China	1.000000	0.08
Fudan University, China	0.200000	0.02

Interested in Oncology and Carcinogenesis?